APA

Koletar S. L., Heald A. E., Finkelstein D., Hafner R., Currier J. S., McCutchan J. A., Vallee M., Torriani F. J., Powderly W. G., Fass R. J. & Murphy R. L. (20011025). A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. : AIDS (London, England).

Chicago

Koletar S L, Heald A E, Finkelstein D, Hafner R, Currier J S, McCutchan J A, Vallee M, Torriani F J, Powderly W G, Fass R J and Murphy R L. 20011025. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. : AIDS (London, England).

Harvard

Koletar S. L., Heald A. E., Finkelstein D., Hafner R., Currier J. S., McCutchan J. A., Vallee M., Torriani F. J., Powderly W. G., Fass R. J. and Murphy R. L. (20011025). A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. : AIDS (London, England).

MLA

Koletar S L, Heald A E, Finkelstein D, Hafner R, Currier J S, McCutchan J A, Vallee M, Torriani F J, Powderly W G, Fass R J and Murphy R L. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. : AIDS (London, England). 20011025.